Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transgenic mouse models and peptide producing endocrine tumours: morpho-functional aspects.

G Rindi, E Solcia, J M Polak

    Experientia. Supplementum
    |January 1, 1989
    PubMed
    Summary

    Transgenic mouse models using simian virus 40 (SV40) large T-antigen developed endocrine tumors, primarily in the pancreas. These models are valuable for studying human endocrine tumor development.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET).

    ESMO open·2025
    Same author

    Synchronous bilateral adrenalectomy in ACTH-dependent hypercortisolism: predictors, biomarkers and outcomes.

    Endocrine·2019
    Same author

    Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study.

    Endocrine·2017
    Same author

    ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.

    Neuroendocrinology·2016
    Same author

    Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis.

    Annals of oncology : official journal of the European Society for Medical Oncology·2015
    Same author

    Pituitary-tumour-transforming-gene 1 expression in testicular cancer.

    Andrologia·2014

    Area of Science:

    • Endocrinology
    • Oncology
    • Genetics

    Background:

    • Transgenic mouse models are crucial for understanding human disease.
    • Endocrine tumors, particularly pancreatic neoplasms, represent a significant health concern.

    Purpose of the Study:

    • To review and discuss three transgenic mouse models that develop endocrine tumors.
    • To evaluate the utility of these models in studying genetically dependent human pathologies.

    Main Methods:

    • Development of transgenic mice expressing simian virus 40 (SV40) large T-antigen.
    • Analysis of tumor development in the pancreas and anterior pituitary.
    • Histopathological examination of neoplastic and non-neoplastic lesions.

    Main Results:

    Related Experiment Videos

    • SV40/metallothionein-growth hormone (MGH), insulin/SV40 (INS/SV40), and vasopressin/SV40 (AVP/SV40) mice developed pancreatic endocrine tumors.
    • Tumors were mainly composed of insulin-producing B cells with a PP cell component.
    • Hyperplasia and dysplasia were observed in INS/SV40 and AVP/SV40 pancreata.
    • AVP/SV40 mice also exhibited tumor genesis in the anterior pituitary.

    Conclusions:

    • Transgenic mouse models effectively replicate human endocrine tumor pathology.
    • These models, particularly INS/SV40 and AVP/SV40, are useful for studying pancreatic endocrine tumors.
    • The models highlight the role of genetic factors in tumor development.